Torrent Pharmaceuticals Ltd

torrentpharma.com

Torrent Pharma, with a market cap of over Rs. 20,000 cr, is a flagship company of the Torrent Group. It is ranked among the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. It has also forayed into the oncology and nephrology segments while also strengthening its focus on gynecology and nutraceuticals segments. Torrent Pharma’s competitive advantage stems from its world-class manufacturing facilities located at Indrad and Dahej in Gujarat, Baddi in Himachal Pradesh and Sikkim in North East, advanced R&D capabilities, extensive domestic network and a widespread global presence across 40 countries.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical

SPOTLIGHT THERAPEUTICS RAISES $36.5 MILLION SERIES B TO ADVANCE A PIPELINE OF CELL-TARGETED IN VIVO CRISPR GENE EDITING BIOLOGICS

Spotlight Therapeutics | March 22, 2022

news image

Spotlight Therapeutics, Inc. (“Spotlight”), a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, today announced a $36.5M Series B financing to fuel a drive toward the clinic. The financing round was co-led by new investors GordonMD Global Investments and EPIQ Capital Group, with participation from Magnetic Ventures, as well as existing investors GV (formerly Google Ventures) and Emerson Collective and other inve...

Read More

DECK 7 INTERVIEWS SANGRAM VAJRE, CO-FOUNDER & CHIEF EVANGELIST AT TERMINUS

PR.com | January 13, 2020

news image

DECK 7 is proud to present an exciting interview with the Co-Founder & Chief Evangelist at Terminus, Sangram Vajre. He is an author, keynote speaker, 3x CMO, host of the daily #FlipMyFunnel podcast, entrepreneur and category maker. Sangram has been a driving force behind the success of Terminus and building the ABM subcategory of marketing technology. Before co-founding Terminus, Sangram was Head of Marketing at Pardot through its acquisition by ExactTarget and then Salesforce. A contributin...

Read More

Medical

VIBE BIO ANNOUNCED THE LAUNCH TO DEVELOP NOVEL TREATMENTS FOR RARE DISEASES

Vibe Bio | June 23, 2022

news image

Vibe Biotechnology Inc., a biotechnology company committed to identifying, funding, and developing promising treatments for rare diseases, announced officially launching with $12 million in funding to advance its community-driven approach to transforming drug development for patients with rare diseases. Vibe Bio plans on building a global community of scientists, researchers, patients, and partners with an aim to find cures for rare diseases by efficiently using a decentralized au...

Read More

MedTech

MEDTRONIC EXPANDS MINIMALLY INVASIVE SPINE SURGERY ECOSYSTEM WITH NEXT-GENERATION SPINAL TECHNOLOGIES

Medtronic plc | October 01, 2021

news image

Medtronic plc, the global leader in medical technology, today announced the latest additions to its minimally invasive spine surgery ecosystem, making it the only company to combine spinal implants, biologics, navigation, robotics, and AI-powered data to surgeons and patients. New additions to the Medtronic MIS+ portfolio include: Catalyft™ PL and PL40, the first releases in the new Catalyft™ Expandable Interbody System. Catalyft™ ...

Read More
news image

Medical

SPOTLIGHT THERAPEUTICS RAISES $36.5 MILLION SERIES B TO ADVANCE A PIPELINE OF CELL-TARGETED IN VIVO CRISPR GENE EDITING BIOLOGICS

Spotlight Therapeutics | March 22, 2022

Spotlight Therapeutics, Inc. (“Spotlight”), a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, today announced a $36.5M Series B financing to fuel a drive toward the clinic. The financing round was co-led by new investors GordonMD Global Investments and EPIQ Capital Group, with participation from Magnetic Ventures, as well as existing investors GV (formerly Google Ventures) and Emerson Collective and other inve...

Read More
news image

DECK 7 INTERVIEWS SANGRAM VAJRE, CO-FOUNDER & CHIEF EVANGELIST AT TERMINUS

PR.com | January 13, 2020

DECK 7 is proud to present an exciting interview with the Co-Founder & Chief Evangelist at Terminus, Sangram Vajre. He is an author, keynote speaker, 3x CMO, host of the daily #FlipMyFunnel podcast, entrepreneur and category maker. Sangram has been a driving force behind the success of Terminus and building the ABM subcategory of marketing technology. Before co-founding Terminus, Sangram was Head of Marketing at Pardot through its acquisition by ExactTarget and then Salesforce. A contributin...

Read More
news image

Medical

VIBE BIO ANNOUNCED THE LAUNCH TO DEVELOP NOVEL TREATMENTS FOR RARE DISEASES

Vibe Bio | June 23, 2022

Vibe Biotechnology Inc., a biotechnology company committed to identifying, funding, and developing promising treatments for rare diseases, announced officially launching with $12 million in funding to advance its community-driven approach to transforming drug development for patients with rare diseases. Vibe Bio plans on building a global community of scientists, researchers, patients, and partners with an aim to find cures for rare diseases by efficiently using a decentralized au...

Read More
news image

MedTech

MEDTRONIC EXPANDS MINIMALLY INVASIVE SPINE SURGERY ECOSYSTEM WITH NEXT-GENERATION SPINAL TECHNOLOGIES

Medtronic plc | October 01, 2021

Medtronic plc, the global leader in medical technology, today announced the latest additions to its minimally invasive spine surgery ecosystem, making it the only company to combine spinal implants, biologics, navigation, robotics, and AI-powered data to surgeons and patients. New additions to the Medtronic MIS+ portfolio include: Catalyft™ PL and PL40, the first releases in the new Catalyft™ Expandable Interbody System. Catalyft™ ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us